BioCentury
ARTICLE | Clinical News

COD ELISA: Began a retrospective trial

April 11, 1994 7:00 AM UTC

Epigen Inc. (EPN), Wellesley, Mass. Product: COD ELISA test to detect human carcinoma antigen, a marker on the cell surface of all epithelial-derived cancers Indication: Monitor breast cancer Status: ...